Several studies have shown that in various cancers, including breast cancer, melanoma, and non-small cell lung cancer, TGF-β promotes CD8+ T cell exhaustion and suppresses anti-tumor immune responses, thereby facilitating tumor progression.32 The gene discussed is CD8A; the disease is breast cancer.